Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06235320

Paracetamol Effect on Prostaglandins and Blood Pressure

Paracetamol Impact Study: Prostaglandin Synthesis and Blood Pressure Effects (PIS-PaB)

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
72 (estimated)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research program aims to investigate the influence of paracetamol on blood pressure and the cyclooxygenase (COX) - prostaglandine (PG) pathway in patients with pain. Through an observational pilot study, we will use advanced LC/ESI-MS/MS methodology to analyze the COX-OG pathway in plasma and urine. The study will assess the effects of paracetamol compared to ibuprofen, considering different types of pain. The primary focus is to understand the changes in blood pressure and the COX-PG pathway upon initiation or discontinuation of paracetamol, with safety analysis as a secondary consideration.

Conditions

Interventions

TypeNameDescription
OTHERroutine clinical treatment of pain with paracetamol or ibuprofenNo intervention beside clinical routine management

Timeline

Start date
2025-03-01
Primary completion
2026-03-01
Completion
2026-09-01
First posted
2024-01-31
Last updated
2025-02-26

Source: ClinicalTrials.gov record NCT06235320. Inclusion in this directory is not an endorsement.

Paracetamol Effect on Prostaglandins and Blood Pressure (NCT06235320) · Clinical Trials Directory